CIC
BEAM icon

Cornercap Investment Counsel’s Beam Therapeutics BEAM Stock Holding History

Cornercap Investment Counsel’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,655
Closed -$212K – 574
2023
Q2 		$212K Buy
+6,655
New +$216K 0.04% 503

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Cornercap Investment Counsel's BEAM Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Beam Therapeutics (BEAM) in Q3 2023, closing a stake of 6,655 shares — an estimated $212K sold.

Cornercap Investment Counsel first reported a position in BEAM in Q2 2023 and held it in 1 quarter. The position peaked at $212K in Q2 2023. 194 funds tracked by Wall St. Rank hold BEAM as of Q3 2023.

  • Cornercap Investment Counsel reported no remaining Beam Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 6,655 Beam Therapeutics shares in Q3 2023, an estimated $212K.
  • Cornercap Investment Counsel first reported a position in Beam Therapeutics in Q2 2023 and held it in 1 quarter.
  • Cornercap Investment Counsel's Beam Therapeutics position peaked at $212K in Q2 2023.
  • 194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.